Marinus Pharmaceuticals: Q4 Earnings Snapshot

March 21, 2022 GMT

RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Monday reported a loss of $28.3 million in its fourth quarter.

The Radnor, Pennsylvania-based company said it had a loss of 77 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.

The epilepsy drug developer posted revenue of $1.5 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $2.6 million.

For the year, the company reported that its loss widened to $98.8 million, or $2.69 per share. Revenue was reported as $15.3 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MRNS at